
Therapeutic Area | MeSH |
|---|---|
| signs and symptoms pathological conditions | D013568 |
Tradename | Company | Number | Date | Products |
|---|---|---|---|---|
| EXPAREL | Pacira BioSciences | N-022496 RX | 2011-10-28 | 2 products, RLD, RS |
Tradename | Company | Number | Date | Products |
|---|---|---|---|---|
| ZYNRELEF KIT | Heron Therapeutics | N-211988 RX | 2021-05-12 | 2 products, RLD, RS |
Tradename | Company | Number | Date | Products |
|---|---|---|---|---|
| SENSORCAINE | Fresenius Kabi | N-018304 RX | 1982-01-01 | 3 products, RLD |
| MARCAINE HYDROCHLORIDE | Hospira | N-016964 RX | 1982-01-01 | 1 products, RLD, RS |
| MARCAINE HYDROCHLORIDE PRESERVATIVE FREE | Hospira | N-016964 RX | 1982-01-01 | 1 products, RLD, RS |
| MARCAINE HYDROCHLORIDE | Hospira | N-016964 RX | 1982-01-01 | 1 products, RLD, RS |
| MARCAINE HYDROCHLORIDE PRESERVATIVE FREE | Hospira | N-016964 RX | 1982-01-01 | 2 products, RLD, RS |
| MARCAINE | Hospira | N-018692 RX | 1984-05-04 | 1 products, RLD, RS |
Tradename | Company | Number | Date | Products |
|---|---|---|---|---|
| SENSORCAINE | Fresenius Kabi | N-018304 RX | 1983-09-02 | 2 products, RLD |
| MARCAINE HYDROCHLORIDE W/ EPINEPHRINE | Hospira | N-016964 RX | 1982-01-01 | 1 products, RLD, RS |
| MARCAINE HYDROCHLORIDE W/ EPINEPHRINE PRESERVATIVE FREE | Hospira | N-016964 RX | 1982-01-01 | 1 products, RLD, RS |
| MARCAINE HYDROCHLORIDE W/ EPINEPHRINE | Hospira | N-016964 RX | 1982-01-01 | 1 products, RLD, RS |
| MARCAINE HYDROCHLORIDE W/ EPINEPHRINE PRESERVATIVE FREE | Hospira | N-016964 RX | 1982-01-01 | 2 products, RLD, RS |
Tradename | Company | Number | Date | Products |
|---|---|---|---|---|
| DUOCAINE | Amphastar Pharmaceuticals | N-021496 DISCN | 2003-05-23 | 1 products |
Brand Name | Status | Last Update |
|---|---|---|
| 0.25% bupivacaine hcl bupivacaine hydrochloride | ANDA | 2024-06-20 |
| blt-25 kit | unapproved drug other | 2024-09-11 |
| bupivacaine | ANDA | 2024-10-25 |
| bupivacaine hci | ANDA | 2024-01-22 |
| bupivacaine hci and epinephrine | ANDA | 2024-01-30 |
| bupivacaine hcl | New Drug Application | 2024-01-27 |
| bupivacaine hcl bupivacine hcl | ANDA | 2023-06-09 |
| bupivacaine hydrochloride | ANDA | 2025-10-03 |
| bupivacaine hydrochloride and epinephrine | ANDA | 2024-10-14 |
| bupivacaine hydrochloride bupivacaine hydrochloride and epinephrine | ANDA | 2024-10-15 |
Expiration | Code | ||
|---|---|---|---|
BUPIVACAINE, EXPAREL, PACIRA PHARMS INC | |||
| 2026-11-09 | I-929 | ||
| 2024-03-22 | NPP | ||
BUPIVACAINE / MELOXICAM, ZYNRELEF KIT, HERON THERAPS INC | |||
| 2024-05-12 | NP | ||
BUPIVACAINE, POSIMIR, INNOCOLL | |||
| 2024-02-01 | NP | ||
Patent | Expires | Flag | FDA Information |
|---|---|---|---|
| Bupivacaine, Exparel, Pacira Pharms Inc | |||
| 11033495 | 2041-01-22 | DP | U-3182 |
| 11179336 | 2041-01-22 | DP | U-3250 |
| 11278494 | 2041-01-22 | DP | U-3250 |
| 11304904 | 2041-01-22 | DP | U-3346 |
| 11311486 | 2041-01-22 | DP | U-3250 |
| 11357727 | 2041-01-22 | DP | U-3380 |
| 11426348 | 2041-01-22 | DP | U-3380 |
| 11452691 | 2041-01-22 | DP | U-3439 |
| 11819574 | 2041-01-22 | DP | U-3250 |
| 11819575 | 2041-01-22 | DP | U-3250 |
| Bupivacaine, Posimir, Innocoll | |||
| 11400019 | 2041-01-12 | DP | |
| 11771624 | 2041-01-12 | U-3724 | |
| 8153149 | 2025-09-15 | DP | |
| 8153661 | 2025-09-15 | U-3074 | |
| 8753665 | 2025-09-15 | DP | U-3074 |
| 8846072 | 2025-09-15 | DP | U-3074 |
| Bupivacaine / Meloxicam, Zynrelef Kit, Heron Theraps Inc | |||
| 11844837 | 2036-04-21 | U-3417 | |
| 9694079 | 2035-04-20 | DP | U-3118 |
| 9801945 | 2035-04-20 | DP | U-3118 |
| 10098957 | 2035-04-20 | U-3118 | |
| 10213510 | 2035-04-20 | DP | U-3118 |
| 10632199 | 2035-04-20 | DP | U-3118 |
| 10898575 | 2035-04-20 | DP | U-3118 |
| 10980886 | 2035-04-20 | DP | |
| 11083730 | 2035-04-20 | DP | U-3118 |
| 11083797 | 2035-04-20 | DP | U-3118 |
| 11413350 | 2035-04-20 | U-3417 | |
| 9592227 | 2034-03-13 | DP | U-3118 |
| 9744163 | 2034-03-13 | DP | |
| 9913909 | 2034-03-13 | U-3118 | |
| 10398686 | 2034-03-13 | DP | |
| 11253504 | 2034-03-13 | U-3118 | |
| Bupivacaine Hydrochloride, Xaracoll, Innocoll Pharms | |||
| 11746141 | 2033-01-09 | DP | |
| RE47826 | 2029-05-20 | U-2949 | |

Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Postoperative pain | D010149 | — | G89.18 | 5 | 9 | 7 | 10 | 3 | 31 |
| Pain | D010146 | EFO_0003843 | R52 | 2 | — | 3 | 7 | — | 12 |
| Pain management | D059408 | — | — | 1 | — | 1 | 2 | 1 | 5 |
| Agnosia | D000377 | EFO_0007136 | F88 | 1 | — | 3 | 1 | — | 5 |
| Intestinal obstruction | D007415 | — | K56.60 | — | — | — | 4 | — | 4 |
| Hernia | D006547 | — | K40-K46 | — | 2 | — | 2 | — | 4 |
| Mammaplasty | D016462 | — | — | — | — | 1 | 2 | — | 3 |
| Analgesia | D000698 | — | — | — | — | 1 | 1 | 1 | 3 |
| Rotator cuff injuries | D000070636 | — | M75.1 | — | — | — | 3 | — | 3 |
| Cesarean section | D002585 | — | — | — | — | — | 2 | — | 2 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Bunion | D000071378 | — | M21.61 | 1 | — | 4 | — | — | 5 |
| Hallux valgus | D006215 | — | — | — | 1 | 2 | — | — | 3 |
| Hemorrhoids | D006484 | EFO_0009552 | K64 | — | — | 2 | — | — | 2 |
| Knee osteoarthritis | D020370 | EFO_0004616 | M17 | — | — | 2 | — | — | 2 |
| Osteoarthritis | D010003 | EFO_0002506 | M15-M19 | — | — | 2 | — | — | 2 |
| Dental pins | D003772 | — | — | — | — | 1 | — | — | 1 |
| Toothache | D014098 | — | K08.89 | — | — | 1 | — | — | 1 |
| Coronary artery disease | D003324 | — | I25.1 | — | — | 1 | — | — | 1 |
| Coronary stenosis | D023921 | EFO_1000882 | — | — | — | 1 | — | — | 1 |
| Mitral valve insufficiency | D008944 | — | — | — | — | 1 | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Inguinal hernia | D006552 | HP_0000023 | K40 | — | 2 | — | — | — | 2 |
| Dupuytren contracture | D004387 | EFO_0004229 | M72.0 | — | 1 | — | — | — | 1 |
| Contracture | D003286 | EFO_0003899 | M62.4 | — | 1 | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Healthy volunteers/patients | — | — | — | 4 | — | — | — | — | 4 |
| Breast implantation | D019928 | — | — | 1 | — | — | — | — | 1 |
| Spinal fusion | D013123 | — | — | 1 | — | — | — | — | 1 |
| Liver diseases | D008107 | EFO_0001421 | K70-K77 | 1 | — | — | — | — | 1 |
| Hepatic insufficiency | D048550 | — | — | 1 | — | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Esthetics | D004954 | — | — | — | — | — | — | 1 | 1 |
| Shoulder injuries | D000070599 | — | — | — | — | — | — | 1 | 1 |
| Anterior cruciate ligament injuries | D000070598 | — | — | — | — | — | — | 1 | 1 |
| Replacement arthroplasty knee | D019645 | — | — | — | — | — | — | 1 | 1 |
| Low back pain | D017116 | — | M54.5 | — | — | — | — | 1 | 1 |
| Bronchiolitis obliterans syndrome | D000092122 | — | D89.811 | — | — | — | — | 1 | 1 |
| Drug common name | Bupivacaine |
| INN | bupivacaine |
| Description | 1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide is a piperidinecarboxamide obtained by formal condensation of the carboxy group of N-butylpipecolic acid with the amino group of 2,6-dimethylaniline. It is a piperidinecarboxamide, an aromatic amide and a tertiary amino compound. It is a conjugate base of a 1-butyl-2-[(2,6-dimethylphenyl)carbamoyl]piperidinium. |
| Classification | Small molecule |
| Drug class | local anesthetics |
| Image (chem structure or protein) | ![]() |
| Structure (InChI/SMILES or Protein Sequence) | CCCCN1CCCCC1C(=O)Nc1c(C)cccc1C |
| PDB | — |
| CAS-ID | 38396-39-3 |
| RxCUI | — |
| ChEMBL ID | CHEMBL1098 |
| ChEBI ID | 77431 |
| PubChem CID | 2474 |
| DrugBank | DB00297 |
| UNII ID | Y8335394RO (ChemIDplus, GSRS) |












